University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 9 of 9
Digoxin Dosing in Heart Failure: A Simplified Nomogram Versus Standard Care
NCT01005602
Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer
NCT00765479
The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers
NCT00594867
A Pilot Observational Clinical Survey: Impacts of Tahitian Noni Juice on the Quality of Life of Patients With Osteoarthritis
NCT01070264
Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
NCT00845845
The Effects of Lycopene on High Risk Prostatic Tissue
NCT01443026
A Randomized Controlled Trial of Mental Health Peer-Led Education
NCT01297985
Intrapulmonary Pharmacokinetics of Antibiotics
NCT00315601
Emend for Multiple-day Emetogenic Chemotherapy
NCT00711555
Treatment of Cystoid Macular Edema in Patients With Retinal Degeneration
NCT00716586
Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
NCT00148083
School-Based Mental Health Services for Urban Children
NCT00612690
Polestriding Versus Walking for Subjects With Poor Leg Circulation
NCT00719355
Evaluation of a Youth Mentoring Program
NCT00158353
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
NCT00592202
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
NCT00566813
Cost Effective Health Promotion for Older Adults
NCT00953030
Lycopene in Preventing Prostate Cancer in Healthy Participants
NCT00093561
Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH
NCT00490464
Lamotrigine Monotherapy in Pediatric Bipolar Disorder
NCT00176228
Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability
NCT00242177
Nurse Managed Upper Body Strength Training in Chronic Obstructive Pulmonary Disease (COPD)
NCT01057797
Duragen Versus Duraguard in Chiari Surgery
NCT00741858
Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
NCT00176202
The Measurement of Empathy and Its Efficacy in Psychotherapy
NCT00620009
Walking Intervention in African American Adults With Newly Diagnosed Hypertension
NCT00298207
Lycopene In Preventing of Prostate Cancer
NCT00006078
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
NCT01499147
Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)
NCT00663442
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00003568
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.